Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bone marrow vascular and stromal niche is a specialized microenvironment within the bone marrow that regulates the maintenance, proliferation, and differentiation of hematopoietic stem cells (HSCs) (Sugiyama & Nagasawa, 2012). It is anatomically and functionally organized into two primary compartments: the endosteal niche, located near the bone surface, and the vascular (perivascular) niche, centered around sinusoidal blood vessels (Frontiers in Oncology, 2022). These niches are composed of a diverse array of cell types, including mesenchymal stromal cells (MSCs), endothelial cells, osteoblasts, and CXCL12-abundant reticular (CAR) cells, which provide essential physical support and biochemical signals such as CXCL12 and stem cell factor (SCF) (NIH, 2023). In diseases like acute myeloid leukemia and multiple myeloma, the niche is often remodeled to create a protective environment that shields malignant cells from chemotherapy and promotes their survival (Nature Reviews Cancer, 2020). Therapeutic strategies targeting this niche aim to disrupt the adhesive interactions between cancer cells and the stroma, such as the CXCR4/CXCL12 or VLA-4/VCAM-1 axes, to mobilize malignant cells into the peripheral circulation where they are more susceptible to treatment (Blood, 2023).
Disruption of retention signals (CXCL12/CXCR4, VCAM-1/VLA-4), mobilization of hematopoietic stem cells, and modulation of the bone marrow microenvironment to enhance chemosensitivity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone marrow vascular and stromal niche (BM niche).